Pancreatic Cancer Research

ResearcherRoyal Marsden NHS Foundation TrustNo recent work listed

Kate Young

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9500-2046; OpenAlex author ID A5087183493. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. Co-author DOI 10.1038/s41467-021-27099-6↗
  2. Immunotherapy and pancreatic cancer: unique challenges and potential opportunities. Co-author DOI 10.1177/1758835918816281↗
  3. Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy. First author DOI 10.1177/1758834016688816↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Naureen Starling · 3 shared papers, 2017–2021 · strength 0.32
  2. David Cunningham · 2 shared papers, 2018–2021 · strength 0.20
  3. Emma Kipps · 1 shared paper, 2017 · strength 0.12
  4. Maria C. Previdi · 1 shared paper, 2021 · strength 0.08
  5. Matteo Fassan · 1 shared paper, 2021 · strength 0.08
  6. Anguraj Sadanandam · 1 shared paper, 2021 · strength 0.08
  7. Jens Claus Hahne · 1 shared paper, 2021 · strength 0.08
  8. Pietro Carotenuto · 1 shared paper, 2021 · strength 0.08
  9. Nigel Balfour Jamieson · 1 shared paper, 2021 · strength 0.08
  10. David J. Watkins · 1 shared paper, 2021 · strength 0.08
  11. Francesco Sclafani · 1 shared paper, 2021 · strength 0.08
  12. Ian Chau · 1 shared paper, 2021 · strength 0.08
  13. Chiara Braconi · 1 shared paper, 2021 · strength 0.08
  14. David Kuang-Fu Chang · 1 shared paper, 2021 · strength 0.08
  15. Andrew Victor Biankin · 1 shared paper, 2021 · strength 0.08
  16. Aldo Scarpa Scarpa · 1 shared paper, 2021 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.